2023 for the Italian Medicines Agency (Aifa), which began with the earthquake of the early exit of the general manager Nicola Magrini, not without political controversy over the spoil system, could continue with the arrival of a woman at the helm of the agency . The assumption is a role as ‘acting’ general management for a transitional period. According to Adnkronos Salute sources, the profile could be that of an internal manager with long experience capable of leading AIFA until the implementation of the reform. On 23 January at 2 pm there will be a meeting of the agency’s board of directors where this changeover could be outlined.
#Aifa #pink #transition #Magrini